SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹525 Cr | ₹474 Cr | ₹414 Cr | ₹343 Cr | ₹369 Cr |
What is the latest Long Term Provisions ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹525 Cr |
| Mar2025 | ₹474 Cr |
| Mar2024 | ₹414 Cr |
| Mar2023 | ₹343 Cr |
| Mar2022 | ₹369 Cr |
How is Long Term Provisions of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹525 Cr | 10.82 | |
| Mar2025 | ₹474 Cr | 14.47 | |
| Mar2024 | ₹414 Cr | 20.70 | |
| Mar2023 | ₹343 Cr | -7.09 | |
| Mar2022 | ₹369 Cr | - | |
Compare Long Term Provisions of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,324.5 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| MANKIND PHARMA | ₹104,275.0 Cr | -0.6% | 6.5% | 7.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 1.2% |
8.3% |
15.5% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses